Not Rated
|
Fund Size
(0.55% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 03-Nov-25 | 9886.10 | -1.14% | - | -1.14% | 114/243 |
| 1 Month | 10-Oct-25 | 9930.70 | -0.69% | - | 0.60% | 192/236 |
| 3 Month | 08-Aug-25 | 10287.80 | 2.88% | - | 4.81% | 194/236 |
| 6 Month | 09-May-25 | 10854.40 | 8.54% | - | 10.40% | 144/225 |
| YTD | 01-Jan-25 | 9750.60 | -2.49% | - | 3.52% | 159/213 |
| 1 Year | 08-Nov-24 | 10067.40 | 0.67% | 0.67% | 2.99% | 130/199 |
| 2 Year | 10-Nov-23 | 14666.80 | 46.67% | 21.07% | 18.74% | 50/153 |
| 3 Year | 10-Nov-22 | 17797.70 | 77.98% | 21.17% | 18.82% | 41/129 |
| 5 Year | 10-Nov-20 | 23271.60 | 132.72% | 18.39% | 21.08% | 66/105 |
| Since Inception | 02-Jul-18 | 38710.00 | 287.10% | 20.18% | 12.30% | 27/218 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 08-Nov-24 | 12000 | 12436.78 | 3.64 % | 6.77 % |
| 2 Year | 10-Nov-23 | 24000 | 27036.96 | 12.65 % | 11.88 % |
| 3 Year | 10-Nov-22 | 36000 | 47884.92 | 33.01 % | 19.39 % |
| 5 Year | 10-Nov-20 | 60000 | 91733.68 | 52.89 % | 16.98 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 3195.6 | 11.57% | 0.65% | 12.5% (Apr 2025) | 10.74% (Jul 2025) | 20.04 L | 90.00 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 2143.1 | 7.76% | -0.39% | 8.53% (Jun 2025) | 4.96% (Oct 2024) | 3.77 L | 5.00 k |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1925.5 | 6.97% | 0.19% | 7.24% (Jul 2025) | 5.22% (Apr 2025) | 9.86 L | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 1719.2 | 6.23% | -0.09% | 6.37% (Jun 2025) | 4.82% (Dec 2024) | 2.32 L | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 1665.8 | 6.03% | -0.27% | 7.6% (Feb 2025) | 6.03% (Sep 2025) | 11.08 L | 0.00 |
| Lupin Ltd. | Pharmaceuticals | 1393.7 | 5.05% | 0.10% | 6.37% (Apr 2025) | 4.94% (Jul 2025) | 7.29 L | 0.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 1195.1 | 4.33% | -1.69% | 8.05% (Oct 2024) | 4.33% (Sep 2025) | 11.03 L | -5.33 L |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 1158.2 | 4.19% | -0.07% | 6.38% (Dec 2024) | 4.13% (Jul 2025) | 9.46 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 1157.1 | 4.19% | 0.30% | 4.19% (Sep 2025) | 2.12% (Jan 2025) | 11.93 L | 0.00 |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 1033.2 | 3.74% | -0.08% | 4.32% (Nov 2024) | 3.57% (Feb 2025) | 14.76 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.25% |
| MF Units | MF Units | 0.01% |
| Net Receivables | Net Receivables | -0.15% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | 1.11 | 15.32 | 52.87 | 38.81 | 36.97 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | 2.27 | 5.61 | 18.93 | 28.13 | 16.21 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 655.17 | 3.89 | 7.41 | 24.70 | 21.37 | 0.00 |
| Franklin Asian Equity Fund - Growth | NA | 279.13 | 2.14 | 11.02 | 23.01 | 20.43 | 14.02 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1651.55 | 0.44 | 11.91 | 27.87 | 20.31 | 0.00 |
| Nippon India Japan Equity Fund - Growth | NA | 292.35 | 1.37 | 3.75 | 12.28 | 18.20 | 16.66 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1419.62 | 2.76 | 6.52 | 11.41 | 16.81 | 0.00 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 3.92 | 7.19 | 11.30 | 16.36 | 13.17 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 2.55 | 5.43 | 13.20 | 16.06 | 19.05 |
| UTI Transportation and Logistics Fund - Growth | NA | 3967.67 | -0.53 | 10.87 | 21.18 | 14.46 | 23.71 |
Out of 101 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 6 is/are ranked 4 * , 5 is/are ranked 3 * , 4 is/are ranked 2 * , and 84 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Mirae Asset Large Cap Fund - Regular - Growth | 3 | 41087.55 | 1.77 | 4.65 | 9.25 | 7.07 | 12.74 |
| Mirae Asset Large & Midcap Fund - Growth | 3 | 40821.90 | 2.06 | 6.61 | 13.63 | 7.40 | 17.00 |
| Mirae Asset ELSS Tax Saver Fund - Regular Plan - Growth | 4 | 25910.64 | 1.78 | 5.73 | 12.03 | 7.88 | 17.01 |
| Mirae Asset Midcap Fund - Regular Plan - Growth | 3 | 17194.25 | 2.33 | 7.58 | 19.23 | 8.82 | 20.46 |
| Mirae Asset Liquid Fund - Growth | 4 | 11367.77 | 0.48 | 1.44 | 3.00 | 6.64 | 6.98 |
| Mirae Asset Aggressive Hybrid Fund - Growth | 3 | 9424.67 | 1.42 | 3.88 | 8.83 | 7.08 | 13.39 |
| Mirae Asset Focused Fund - Growth | 2 | 7769.11 | 0.74 | 3.42 | 9.38 | 2.51 | 11.31 |
| Mirae Asset Nifty 50 ETF (MAN50ETF) | 4 | 4714.74 | 1.77 | 4.80 | 8.05 | 7.74 | 13.10 |
| Mirae Asset Nifty 50 ETF (MAN50ETF) | 4 | 4714.74 | 1.77 | 4.80 | 8.05 | 7.74 | 13.10 |
| Mirae Asset Great Consumer Fund - Growth | NA | 4632.32 | -0.29 | 3.96 | 10.01 | 3.84 | 16.94 |